Agenus to participate in b. riley securities precision oncology & radiopharma investor conference

Lexington, mass.--(business wire)--agenus inc. (nasdaq: agen), a leader in immuno-oncology, today announced participation in a panel discussion at the b. riley securities precision oncology & radiopharma investor conference that will take place on friday, february 28th in new york. panel discussion details: speaker: robin taylor, ph.d., chief commercial officer topic: “what it takes to move the needle in improving responses in colorectal cancer”' date: 02/28/2025 time: 1:00-2:00 p.m. et loc.
AGEN Ratings Summary
AGEN Quant Ranking